{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:59:52Z","timestamp":1791518392053,"version":"4.3.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["U1SHA46532"],"award-info":[{"award-number":["U1SHA46532"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s10461-024-04610-w","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T13:47:58Z","timestamp":1741009678000},"page":"1704-1712","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Universal Approach to Educating Patients with HIV about Long-Acting Injectable Treatment for HIV"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6787-295X","authenticated-orcid":false,"given":"Bijou","family":"Hunt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Glick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Sam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyang","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrine","family":"Meyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"key":"4610_CR1","unstructured":"Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2017\u20132021. HIV Surveillance Supplemental Report. 2023; 28 (No.3). http:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance.html. Published May 2023. Accessed October 5, 2023."},{"issue":"13","key":"4610_CR2","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1056\/NEJM199803263381301","volume":"338","author":"FJ Palella Jr","year":"1998","unstructured":"Palella FJ Jr., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study investigators. N Engl J Med. 1998;338(13):853\u201360.","journal-title":"N Engl J Med"},{"issue":"4","key":"4610_CR3","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/QAI.0000000000002277","volume":"83","author":"N Crepaz","year":"2020","unstructured":"Crepaz N, et al. Brief report: racial and ethnic disparities in sustained viral suppression and transmission risk potential among persons aged 13\u201329 years living with diagnosed HIV infection, United States, 2016. J Acquir Immune Defic Syndr. 2020;83(4):334\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"4610_CR4","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s40615-015-0141-8","volume":"3","author":"KL Allgood","year":"2016","unstructured":"Allgood KL, Hunt B, Rucker MG. Black:White disparities in HIV Mortality in the United States: 1990\u20132009. J Racial Ethn Health Disparities. 2016;3(1):168\u201375.","journal-title":"J Racial Ethn Health Disparities"},{"issue":"2","key":"4610_CR5","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/JNC.0000000000000386","volume":"34","author":"RM Pinto","year":"2023","unstructured":"Pinto RM, Hall E, Tomlin R. Injectable Long-Acting Cabotegravir-Rilpivirine therapy for people living with HIV\/AIDS: addressing implementation barriers from the start. J Assoc Nurses AIDS Care. 2023;34(2):216\u201320.","journal-title":"J Assoc Nurses AIDS Care"},{"issue":"2","key":"4610_CR6","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s11606-022-07687-y","volume":"38","author":"SR Bunting","year":"2023","unstructured":"Bunting SR, et al. Examining the correlation between PrEP Use and Black:White disparities in HIV incidence in the ending the HIV Epidemic Priority jurisdictions. J Gen Intern Med. 2023;38(2):382\u20139.","journal-title":"J Gen Intern Med"},{"issue":"6","key":"4610_CR7","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2105\/AJPH.2009.170241","volume":"100","author":"MS Rubin","year":"2010","unstructured":"Rubin MS, Colen CG, Link BG. Examination of inequalities in HIV\/AIDS mortality in the United States from a fundamental cause perspective. Am J Public Health. 2010;100(6):1053\u20139.","journal-title":"Am J Public Health"},{"key":"4610_CR8","unstructured":"Jara S, N\u00fa\u00f1ez-Montelongo L, Castro M, Casta\u00f1eda Y, Roesch PT, Margellos-Anast H. (2022). 2022 MSH Community Health Needs Assessment. sinaichicago.org. https:\/\/www.sinaichicago.org\/wp-content\/uploads\/2022\/06\/Sinai-Chicago-2022-CHNA_Mount-Sinai-Hospital_final-compressed.pdf"},{"key":"4610_CR9","volume-title":"HIV\/STI Surveillance Report, 2019","author":"Chicago Department of Public Health","year":"2020","unstructured":"Chicago Department of Public Health. HIV\/STI Surveillance Report, 2019. Chicago, IL: City of Chicago; Dember; 2020."},{"key":"4610_CR10","unstructured":"Hirschtick J, Benjamins M, Homan S. Community Health Counts: Sinai Community Health Survey 2.0. Chicago, IL: Sinai Urban Health Institute, Sinai Health System; 2017. https:\/\/www.sinaisurvey.org\/_files\/ugd\/6b5ac9_bee17298461e4e00862737df7b304ca4.pdf"},{"issue":"S1","key":"4610_CR11","doi-asserted-by":"publisher","first-page":"e26282","DOI":"10.1002\/jia2.26282","volume":"27","author":"N Nguyen","year":"2024","unstructured":"Nguyen N, et al. Long-acting injectable ART to advance health equity: a descriptive analysis of US clinic perspectives on barriers, needed support and programme goals for implementation from applications to the ALAI UP Project. J Int AIDS Soc. 2024;27(S1):e26282.","journal-title":"J Int AIDS Soc"},{"key":"4610_CR12","unstructured":"Initiative SPNS.: Accelerating Implementation of Long-Acting Injectables (2022\u20132026). TargetHIV; Available from: https:\/\/targethiv.org\/org\/spns-initiative-accelerating-implementation-long-acting-injectables-2022-2026"},{"issue":"3","key":"4610_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1089\/apc.2018.0198","volume":"33","author":"JM Simoni","year":"2019","unstructured":"Simoni JM, et al. Long-acting Injectable Antiretroviral Treatment Acceptability and preferences: a qualitative study among US Providers, adults living with HIV, and parents of Youth living with HIV. AIDS Patient Care STDS. 2019;33(3):104\u201311.","journal-title":"AIDS Patient Care STDS"},{"issue":"1","key":"4610_CR14","doi-asserted-by":"publisher","first-page":"e0190487","DOI":"10.1371\/journal.pone.0190487","volume":"13","author":"D Kerrigan","year":"2018","unstructured":"Kerrigan D, et al. Experiences with long acting injectable ART: a qualitative study among PLHIV participating in a phase II study of cabotegravir\u2009+\u2009rilpivirine (LATTE-2) in the United States and Spain. PLoS ONE. 2018;13(1):e0190487.","journal-title":"PLoS ONE"},{"issue":"3","key":"4610_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/QAI.0000000000002337","volume":"84","author":"MM Philbin","year":"2020","unstructured":"Philbin MM, et al. Multisite Study of women living with HIV\u2019s Perceived barriers to, and interest in, Long-Acting Injectable Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2020;84(3):263\u201370.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"4610_CR16","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/QAI.0000000000001896","volume":"80","author":"ED Weld","year":"2019","unstructured":"Weld ED, et al. Interest of Youth Living with HIV in Long-Acting antiretrovirals. J Acquir Immune Defic Syndr. 2019;80(2):190\u20137.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"4610_CR17","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1089\/aid.2020.0107","volume":"36","author":"K Dub\u00e9","year":"2020","unstructured":"Dub\u00e9 K, et al. Reasons people living with HIV might prefer oral daily antiretroviral therapy, long-acting formulations, or future HIV Remission options. AIDS Res Hum Retroviruses. 2020;36(12):1054\u20138.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"6","key":"4610_CR18","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1080\/09540121.2020.1764906","volume":"33","author":"D Dandachi","year":"2021","unstructured":"Dandachi D, et al. Acceptability and preferences for long-acting antiretroviral formulations among people with HIV infection. AIDS Care. 2021;33(6):801\u20139.","journal-title":"AIDS Care"},{"issue":"Suppl 2","key":"4610_CR19","doi-asserted-by":"publisher","first-page":"e26099","DOI":"10.1002\/jia2.26099","volume":"26","author":"SM Graham","year":"2023","unstructured":"Graham SM, et al. U.S. patient preferences for long-acting HIV treatment: a discrete choice experiment. J Int AIDS Soc. 2023;26(Suppl 2):e26099.","journal-title":"J Int AIDS Soc"},{"issue":"12","key":"4610_CR20","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1007\/s10461-020-02918-x","volume":"24","author":"A Mantsios","year":"2020","unstructured":"Mantsios A, et al. Efficacy and freedom: patient experiences with the transition from daily oral to long-acting Injectable Antiretroviral Therapy to treat HIV in the context of phase 3 trials. AIDS Behav. 2020;24(12):3473\u201381.","journal-title":"AIDS Behav"},{"issue":"Suppl 4","key":"4610_CR21","doi-asserted-by":"publisher","first-page":"S541","DOI":"10.1093\/cid\/ciac716","volume":"75","author":"SE Cooper","year":"2022","unstructured":"Cooper SE, Rosenblatt J, Gulick RM. Barriers to Uptake of Long-Acting Antiretroviral products for Treatment and Prevention of Human Immunodeficiency Virus (HIV) in high-income countries. Clin Infect Dis. 2022;75(Suppl 4):S541\u20138.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"4610_CR22","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1186\/s12913-024-11165-y","volume":"24","author":"J Oliver","year":"2024","unstructured":"Oliver J, et al. Community health workers\u2019 dissemination of COVID-19 information and services in the early pandemic response: a systematic review. BMC Health Serv Res. 2024;24(1):711.","journal-title":"BMC Health Serv Res"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-024-04610-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-024-04610-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-024-04610-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T13:02:20Z","timestamp":1745672540000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-024-04610-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["4610"],"URL":"https:\/\/doi.org\/10.1007\/s10461-024-04610-w","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,3]]},"assertion":[{"value":"30 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}